Length of Detoxification
Because detoxification often entails a more intensive level
of care than other types of AOD treatment, there is a practical
value in defining a period during which a person is "in detoxification." There
is no simple way to do this. Usually, the detoxification
period is defined as the period during which the patient
receives detoxification medications.
--------------------------------------------------------------------------------
Third-party payers often manage payment for AOD detoxification services separately
from other phases of drug treatment, as though detoxification occurs in isolation
from drug treatment. In clinical practice, this separation cannot exist. Detoxification
is one component of a comprehensive treatment strategy.
--------------------------------------------------------------------------------
Another way of defining the detoxification period is by
measuring the duration of withdrawal signs or symptoms. However,
the duration of these symptoms may be difficult to determine
in a correctly medicated patient because symptoms of withdrawal
are largely suppressed by the medication. Chapter 3 describes
the typical lengths of regimens for withdrawal.
The Role of Detoxification in AOD Abuse Treatment
For many AOD-dependent patients, detoxification is the beginning
phase of treatment. It can entail more than a period of physical
readjustment. It can also be a time when patients begin to
make the psychological readjustments necessary for ongoing
treatment. Offering detoxification alone, without followup
to an appropriate level of care, is an inadequate use of
limited resources. People who have severe problems that predate
their AOD dependence or addiction -- such as family disintegration,
lack of job skills, illiteracy, or psychiatric disorders
-- may continue to have these problems after detoxification
unless specific services are available to help them deal
with these factors (Gerstein and Harwood, 1990).
Immediate Goals of Detoxification
To provide a safe withdrawal from the drug(s) of dependence
and enable the patient to become drug free. Many risks are
associated with withdrawal, some influenced by the setting.
For persons who are severely dependent on alcohol, abrupt,
unsupervised cessation of drinking may result in delirium
tremens or death. Other sedative-hypnotics may produce life-threatening
withdrawal syndromes. Withdrawal from opioids produces severe
discomfort, but is not generally life threatening. However,
risks to the patient and society are not limited to the severity
of the patient's physical disturbance, particularly when
the detoxification is conducted in an outpatient setting.
Outpatients experiencing withdrawal symptoms may self-medicate
with street drugs. The resulting interaction between prescribed
medication and street drugs may result in an overdose. Less
severe side effects include sedation or a drop in blood pressure.
To provide withdrawal that is humane and protects the patient's
dignity. A caring staff, a supportive environment, sensitivity
to cultural issues, confidentiality, and the selection of
appropriate detoxification medication (if needed) are all
important to providing humane withdrawal.
To prepare the patient for ongoing treatment of his or her
AOD dependence. During detoxification, patients may form
therapeutic relationships with treatment staff or other patients,
and may become aware of alternatives to an AOD-abusing lifestyle.
Detoxification is an opportunity to offer patients information
and to motivate them for longer term treatment.
Repeated Detoxification
Alling discussed detoxification and treatment in a text
published in 1992:
Those not familiar with the chronic nature of addictive
disorders often characterize detoxification programs as 'revolving
doors' through which patients come and go in an endless cycle,
and which have little or no impact on the recovery process.
Although it is true that many people undergo detoxification
more than once -- and some do so many times -- the assumption
that little or no progress has been made is often false.
(Alling, 1992)
Alling(1992) described a pattern in individuals who return
for several detoxification episodes, observing that young
people with a history of AOD dependence of short duration
(a year or less) "often are unrealistically optimistic about
being able to remain drug free following detoxification." When
recently AOD-dependent persons return after several months
for repeat detoxification, it is usually with a more realistic
expectation about what is needed to remain free from AODs.
Individuals who subsequently relapse and return for detoxification
a third time may have an even clearer understanding of what
is required to sustain recovery (Alling, 1992).
During certain expected and predictable phases of recovery,
addicted persons are at increased risk of relapse. However,
relapse can occur at any point in recovery. Thus, relapse
prevention is a legitimate area for patient education, and
the relapsed patient is appropriate for clinical treatment.
Treatment services designed precisely for this stage of the
disease may facilitate the individual's return to abstinence.
Issues in Postdetoxification Treatment
Few addicted persons enter detoxification or seek further
treatment with the idea of maintaining lifelong abstinence.
They may still believe they can control their abuse of AODs.
Some persons enter detoxification and other treatment to
satisfy the demands of their families, employers, or the
courts. They may be motivated to seek treatment because attempts
to relieve pressure through other means have proved futile.
Clinicians should consider patient motivation when deciding
upon appropriate treatment placement.
Families suffer severe consequences from the AOD abuse of
their loved ones. The consequences may include obvious problems
such as lost income, domestic violence, or divorce. Less
obvious consequences may also occur, such as issues concerning
trust and children's mirroring maladaptive ways to deal with
problems encountered in everyday living. Addiction is a family
disease because of the seriousness of its effects on family
members and family functioning. Just as the person who abuses
AODs needs support, education, and counseling, so too does
the family. It is appropriate and important for treatment
providers to engage the family in treatment as early as possible,
even while the individual is undergoing detoxification.
Effects of AOD Exposure and Withdrawal
Tolerance and Physical Dependence
Continued exposure to AODs induces adaptive changes in an
individual's brain cells and neural functioning. The changes
vary depending on the drug of abuse and are not completely
understood. The term "neuroadaptation" is often used to refer
to these changes. One result of neuroadaptation is drug tolerance;
that is, increasing the amounts of the drug that are required
to produce the same effect. A second consequence of neuroadaptation
is physical dependence; the brain cells require the drug
in order to function.
Drug Withdrawal
Sudden removal of alcohol or another drug of abuse from
the system of a person who is physically dependent produces
either an abstinence or withdrawal syndrome. The abstinence
syndrome for each drug follows a predictable time course
and has predictable signs and symptoms. Signs are defined
by Webster's Medical Dictionary as "objective evidence of
disease especially as observed and interpreted by the physician
rather than by the patient or lay observer." Symptoms are
defined in the same text as "subjective evidence of disease
or physical disturbance observed by the patient."
--------------------------------------------------------------------------------
There are three immediate goals of detoxification:
- To provide a safe withdrawal from the drug(s) of dependence
and enable the patient to become drug free
- To provide withdrawal that is humane and protects the
patient's dignity
- To prepare the patient for ongoing treatment of his or
her AOD dependence
--------------------------------------------------------------------------------
The signs and symptoms of drug withdrawal are usually the
reverse of the direct pharmacological effects of the drug.
Heroin use commonly produces elevation of mood (euphoria),
a decrease in anxiety, insensitivity to pain (analgesia),
and a decrease in the activity of the large intestine, often
causing constipation. Heroin withdrawal, on the other hand,
produces an unpleasant mood (dysphoria), pain, anxiety, and
overactivity of the large intestine, often resulting in diarrhea.
Alcohol usually reduces anxiety and causes sedation; large
quantities may produce sleep, coma, or even death by respiratory
depression. In a person who is physically dependent, cessation
of alcohol use produces anxiety, insomnia, hallucinations,
and seizures.
For short-acting drugs such as alcohol and heroin, the most
severe signs and symptoms of withdrawal usually begin within
hours of the individual's last use. With a long-acting drug
or medication, such as diazepam (Valium), withdrawal symptoms
may not begin for several days and usually reach peak intensity
after 5 to 10 days. The most severe drug-withdrawal symptoms,
during the initial stages of detoxification, constitute the
acute abstinence syndrome. The adjective "acute" distinguishes
the syndrome from a "chronic" or protracted abstinence syndrome,
in which signs and symptoms of withdrawal may continue for
weeks to months after cessation of use (Martin and Jasinski,
1969).
--------------------------------------------------------------------------------
The signs and symptoms of drug withdrawal are usually the reverse of the direct
pharmacological effects of the drug.
--------------------------------------------------------------------------------
Protracted abstinence syndrome is the subject of considerable
controversy. Providers often find it difficult to distinguish
symptoms caused by drug withdrawal from those caused by a
patient's underlying mental disorder, if one is present.
The signs and symptoms of protracted withdrawal are not as
predictable as those of acute withdrawal. Some patients may
be predisposed to a protracted withdrawal. Acute withdrawal
syndromes produce measurable signs that researchers can study
in animals under controlled laboratory conditions; protracted
withdrawal in patients, by contrast, is often confined to
distress symptoms that cannot be studied in animals.
Source: U.S. Department of Health and Human Services